List of authorized vaccines and treatments for COVID-19

Product name Company name Product type Status Date of approval Approved for different indication ID
SPIKEVAX Bivalent (elasomeran/ imelasomeran) ModernaTX, Inc. Vaccine Authorized No 111
EVUSHELD (cilgavimab / tixagevimab) AstraZeneca Canada Inc. Treatment Authorized No 109
Covifenz (virus-like particles (VLP) of SARS-CoV-2 spike protein) Medicago Inc Vaccine Authorized No 106
NUVAXOVID (SARS-CoV-2 recombinant spike protein) Novavax Inc Vaccine Authorized No 104
PAXLOVID (nirmatrelvir / ritonavir) Pfizer Canada ULC Treatment Authorized No 102
Sotrovimab (sotrovimab) GlaxoSmithKline Inc Treatment Authorized By Interim Order No 36
Casirivimab and imdevimab (casirivimab / imdevimab) Hoffmann-La Roche Limited Treatment Authorized By Interim Order No 34
JCOVDEN (Ad26.COV2.S [recombinant]) Previously Janssen COVID-10 Vaccine Janssen Inc Vaccine Authorized By Interim Order No 27
Vaxzevria (ChAdOx1-S [recombinant]) previously Astrazeneca Covid-19 Vaccine AstraZeneca Canada Inc. Vaccine Authorized By Interim Order No 28
COVISHIELD (ChAdOx1-S [recombinant]) Expired September 16 2021 Verity Pharmaceuticals Inc/Serum Institute of India (in partnership with AstraZeneca Canada Inc) Vaccine Authorized By Interim Order No 29
SPIKEVAX (elasomeran) previously COVID-19 Vaccine Moderna ModernaTX, Inc. Vaccine Authorized By Interim Order No 15
Comirnaty (tozinameran) previously Pfizer-BioNTech COVID-19 Vaccine BioNTech Manufacturing GmbH Vaccine Authorized By Interim Order No 16
Bamlanivimab (bamlanivimab) Eli Lilly Canada Inc Treatment Authorized By Interim Order No 8
Veklury (remdesivir) Gilead Sciences Canada Inc Treatment Authorized No 9
Olumiant (baricitinib) Eli Lilly Canada Inc Treatment Under review Under review Yes 39
Regdanvimab (regdanvimab) Celltrion HealthCare Co Ltd Treatment Under review Under review No 53
COVID-19 Vaccine Moderna – Application for Pediatric Use (ages 12-17) (mRNA-1273 SARS-CoV-2) ModernaTX, Inc. Vaccine Under review Under review No 55
Nitric oxide (nitric oxide) Sanotize Research & Development Corp. Treatment Under review Under review Yes 76
Coronavirus-like Particle (CoVLP) COVID-19 Vaccine (coronavirus-like particle [CoVLP]) Medicago Inc Vaccine Under review Under review No 38
Leronlimab (leronlimab) CytoDyn, Inc. Treatment Under review Under review No 35
Bamlanivimab and etesevimab (LY-CoV555 / LY-CoV016) Eli Lilly Canada Inc Treatment Under review Under review No 32
Novavax COVID-19 Vaccine (NVX-CoV2373) Novavax Inc Vaccine Under review Under review No 31
Favipiravir (favipiravir) Dr Reddys Laboratories Ltd Treatment Under review Under review 17